HLA-A*11:01 EBV LMP2 Tetramer-SSCSSCPLSK-PE

MBL Life Sciences

Catalog No.: MBL-TS-M111-1

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

• Application: FC
• Reactivity: Human
• Conjugation: PE
• Immunogen: EBV LMP2
• Peptide Sequence: SSCSSCPLSK
• Class: Class I
• Sequence Location: 340-349
• MHC Allele: A*11:01